Cardicomm Solutions, Inc. Press Releases

TORONTO, ONTARIO – October 31, 2013, CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 33,626 common shares of the Company in settlement of services provided, as previously described in the Company’s press release dated October 11, 2013. The shares were issued to Mr. Simi...

ZoomerShow Participation Caps Off a Busy Week of Marketing Initiatives to Build Mindshare for the HeartCheck™ PEN Handheld ECG Device TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) will promote consumer awareness of the HeartCheck™ PEN handheld ECG device and offer free ECG readings to visitors this weekend (October 26th to 27th) during the ZoomerShow at the Direct Energy Centre in...

Interest grows as select pharmacies carry the HeartCheck™ PEN for sale in Ontario TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE: EKG) today announced that Remedy’sRx pharmacies have joined the Company’s campaign to promote awareness of the HeartCheck™ PEN. Select pharmacies in more Ontario cities will now be carrying the HeartCheck™ PEN for sale to consumers. ...

TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirms results from the use of the HeartCheck™ ECG Monitor were presented today at Vascular 2013 in Montreal. Researchers from three University of Toronto teaching hospitals and the Centre for Innovation in Complex Care developed the protocol for the national program that screened for Atrial Fibrillation (“AF”) as a risk factor for...

Toronto, Canada – CardioComm Solutions, Inc. ("CardioComm Solutions" or the "Company") (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it intends to issue an aggregate of 33,626 common shares of the Company to Simi Grosman, a director of the Company. The shares will be issued at a deemed price of $0.134 per share, for a total value of $4,500, for services rendered to the Company in the months of July,...

CIHR and industry sponsored study to use HeartCheck™ PEN and ECG monitors to screen 8,000 people through in-pharmacy and primary care physician offices for stroke risk   Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it is working with the Canadian Atrial...

Select Total Health Pharmacies in Ontario to carry the HeartCheck™ PEN in association with the “Take Control” commercial airing on the CBC television network TORONTO, ONTARIO – CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE: EKG) today announced that it has launched a television commercial campaign to promote awareness of the HeartCheck™ PEN and signaling its availability for sale in select...

CEO Interview reviews opportunities in both the consumer and medical ECG services market TORONTO, ONTARIO – CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE: EKG) confirms that a recent interview with the Wall Street Analyst (WSA) will be featured on the front page of www.thewallstreetanalysts.com for two business days. The interview with Etienne Grima, the Company’s Chief Executive Officer, will be made available to their global investor audience which...

TORONTO, ONTARIO – September 20, 2013, CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 175,979 common shares of the Company in settlement of services provided to CardioComm Solutions by The Lightning Group Ltd. (“TLG”) and LOLA Social Marketing Inc....

 Results from the Heart and Stroke Foundation “Be Pulse Aware” ECG Screening Campaign will be released during Vascular 2013 TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) confirms results from the use of the HeartCheck™ ECG Monitor will be presented at Vascular 2013, a one-time Canadian event of four separate scientific meetings: the Canadian Cardiovascular Congress, the...

 The Zoomer Publication targets population of 15.1 million baby boomers in the Canadian market TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) is pleased to announce that the HeartCheck™ PEN ECG device and SMART Monitoring service were the subject of a special article in the October 2013 issue of Zoomer Magazine, published by ZoomerMedia Limited. Zoomer Magazine is published nine times a...

North America plans will utilize social media strategies including calls to action for arrhythmia screening in sports TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today announced that it has engaged The Lightning Group (“TLG”) and LOLA Social Marketing (“LOLA”) to provide on-line marketing and social media strategy services. In exchange for these services, CardioComm...

Enhancements include symptom correlation to ECG readings TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirms it has released a new version of its GEMS Home software which is available to both new purchasers of the HeartCheckTM PEN ECG device as well as a free upgrade to current HeartCheckTM PEN owners. CardioComm Solutions has long history of licensing its Global ECG Management System...

Customer advocacy program to provide media promotion of CardioComm Solutions Case Study TORONTO, ONTARIO - CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”) today confirmed SunGard Availability Services (Canada) Ltd, a subsidiary of SunGard Data Systems Inc. (“SunGard’), will be promoting CardioComm Solutions in a case study related to the Company’s use of their cloud-based systems infrastructure as...

TORONTO, ONTARIO – August 9, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 250,000 options to the Company’s CEO, Etienne Grima, in accordance with his employment agreement with the Company. The options are exercisable at $0.19 per share for five years from the date of...

Coverage is Geared to Matching Investors with Innovations in Healthcare and Finance Toronto, Canada  – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or “the Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced that it has contracted Crystal Research Associates, LLC (“Crystal Research”), a New York-based independent equity research...

TORONTO, ONTARIO - August 2, 2013. CardioComm Solutions, Inc. ("CardioComm Solutions" or the "Company") (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 377,129 common shares of the Company in settlement of services provided, as previously described in the Company's press release dated July 12, 2013. A total of 350,000 common shares were issued at a deemed price of $0.15 per...

TORONTO, ONTARIO -July 12, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has agreed to issue 350,000 common shares of the Company at a deemed price of $0.15 per share as compensation for $52,500 worth of services provided to the Company by an arm’s length service provider. The services provided were...

ECG monitoring to be performed by Sunnybrook Hospital (Toronto) through in-home SMART Monitoring services. Toronto, Canada – CardioComm Solutions, Inc. (TSX-V:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, announced it is working with clinicians at Sunnybrook Hospital in Toronto to use the HeartCheckTM PEN handheld ECG device and SMART...

TORONTO, ONTARIO -May 21, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), today announced that the Company has issued 29,201 shares to Mr. Simi Grosman, an independent member of the board of directors, for services rendered to the Company in the months of January, February and March of 2013. The shares were issued at a 5% premium to the closing price of the Company's shares at the end of each month. The total...

The HeartCheck PEN ECG device is the first to utilize the patent pending SMART Monitoring technologies to enable/unlock a consumer medical devices to record, display, transmit and receive bio-signals and images. TORONTO, ONTARIO -May 9, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of electrocardiogram (“ECG”) acquisition and management software solutions, today...

Leveraging national health care call centre infrastructure, North American HeartCheck PEN Consumers will have around the clock access to rapid physician ECG interpretations. TORONTO, ONTARIO – April 24, 2013. CardioComm Solutions, Inc. (TSX VENTURE:EKG) ("CardioComm Solutions" or the "Company"), a global medical provider of electrocardiogram ("ECG") acquisition and management software solutions, today formally announced expansion of the Company's SMART Monitoring Service...

TORONTO, ONTARIO –April 19, 2013. CardioComm Solutions, Inc. (“CardioComm Solutions” or the “Company”) (TSX VENTURE:EKG), a global medical provider of ECG acquisition and management software solutions, today announced that it has issued an aggregate of 750,000 stock options. 250,000 options were issued to the Company’s CEO, Etienne Grima, in accordance with his employment, and 500,000 options were issued to senior managers of the Company. All...